172 related articles for article (PubMed ID: 34419381)
1. Survival Outcomes After Immediate Radical Cystectomy Versus Conservative Management with Bacillus Calmette-Guérin Among T1 High-grade Micropapillary Bladder Cancer Patients: Results from a Multicentre Collaboration.
Lonati C; Baumeister P; Afferi L; Mari A; Minervini A; Krajewski W; Azizi S; Hendricksen K; Martini A; Necchi A; Montorsi F; Briganti A; Colombo R; Tafuri A; Antonelli A; Cerruto MA; Rouprêt M; Masson-Lecomte A; Laukhtina E; D'Andrea D; Shariat SF; Soria F; Marra G; Gontero P; Contieri R; Hurle R; Valiquette AS; Mir MC; Zamboni S; Simeone C; Klatte T; Teoh JY; Yoshida S; Fujii Y; Carando R; Schulz GB; Mordasini L; Mattei A; Moschini M;
Eur Urol Focus; 2022 Sep; 8(5):1270-1277. PubMed ID: 34419381
[TBL] [Abstract][Full Text] [Related]
2. Immediate radical cystectomy versus BCG immunotherapy for T1 high-grade non-muscle-invasive squamous bladder cancer: an international multi-centre collaboration.
Lonati C; Afferi L; Mari A; Minervini A; Krajewski W; Borghesi M; Schulz GB; Rink M; Montorsi F; Briganti A; Colombo R; Martini A; Necchi A; Contieri R; Hurle R; Umari P; Zamboni S; Simeone C; Soria F; Marra G; Gontero P; Teoh JY; Klatte T; Bajeot AS; Roumiguié M; Rouprêt M; Masson-Lecomte A; Laukhtina E; Valiquette AS; Mir MC; Antonelli A; Einerhand SMH; Hendricksen K; Carando R; Fankhauser CD; Baumeister P; Mattei A; Shariat SF; Moschini M;
World J Urol; 2022 May; 40(5):1167-1174. PubMed ID: 35218372
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes of cT1 micropapillary bladder cancer.
Willis DL; Fernandez MI; Dickstein RJ; Parikh S; Shah JB; Pisters LL; Guo CC; Henderson S; Czerniak BA; Grossman HB; Dinney CP; Kamat AM
J Urol; 2015 Apr; 193(4):1129-34. PubMed ID: 25254936
[TBL] [Abstract][Full Text] [Related]
4. Using Grade of Recurrent Tumor to Guide Further Therapy While on Bacillus Calmette-Guerin: Low-grade Recurrences Are not Benign.
Li R; Metcalfe MJ; Tabayoyong WB; Guo CC; Nogueras González GM; Navai N; Grossman HB; Dinney CP; Kamat AM
Eur Urol Oncol; 2019 May; 2(3):286-293. PubMed ID: 31200843
[TBL] [Abstract][Full Text] [Related]
5. Oncological Outcomes for Patients with European Association of Urology Very High-risk Non-muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin or Early Radical Cystectomy.
Contieri R; Hensley PJ; Tan WS; Grajales V; Bree K; Nogueras-Gonzalez GM; Lee BH; Navai N; Dinney CP; Kamat AM
Eur Urol Oncol; 2023 Dec; 6(6):590-596. PubMed ID: 37558542
[TBL] [Abstract][Full Text] [Related]
6. Papillary Recurrence of Bladder Cancer at First Evaluation after Induction Bacillus Calmette-Guérin Therapy: Implication for Clinical Trial Design.
Mmeje CO; Guo CC; Shah JB; Navai N; Grossman HB; Dinney CP; Kamat AM
Eur Urol; 2016 Nov; 70(5):778-785. PubMed ID: 26922408
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcome of patients with T1 micropapillary urothelial carcinoma of the bladder.
Spaliviero M; Dalbagni G; Bochner BH; Poon BY; Huang H; Al-Ahmadie HA; Donahue TF; Taylor JM; Meeks JJ; Sjoberg DD; Donat SM; Reuter VE; Herr HW
J Urol; 2014 Sep; 192(3):702-7. PubMed ID: 24603101
[TBL] [Abstract][Full Text] [Related]
8. T1G3 high-risk NMIBC (non-muscle invasive bladder cancer): conservative treatment versus immediate cystectomy.
De Berardinis E; Busetto GM; Antonini G; Giovannone R; Gentile V
Int Urol Nephrol; 2011 Dec; 43(4):1047-57. PubMed ID: 21442469
[TBL] [Abstract][Full Text] [Related]
9. Influence of lamina propria invasion extension on T1 high-grade non-muscle-invasive bladder cancer in patients undergoing BCG or radical cystectomy.
Contieri R; Tan WS; Grajales V; Hensley PJ; Martini A; Bree K; Myers A; Nogueras-Gonzalez G; Navai N; Dinney CP; Guo C; Kamat AM
BJU Int; 2024 Jun; 133(6):733-741. PubMed ID: 38374533
[TBL] [Abstract][Full Text] [Related]
10. Patterns of recurrence and outcomes following induction bacillus Calmette-Guerin for high risk Ta, T1 bladder cancer.
Lerner SP; Tangen CM; Sucharew H; Wood D; Crawford ED
J Urol; 2007 May; 177(5):1727-31. PubMed ID: 17437798
[TBL] [Abstract][Full Text] [Related]
11. Bladder-sparing Treatment in Patients with Bacillus Calmette-Guerin-unresponsive Non-muscle-invasive Bladder Cancer: An Analysis of Long-term Survival Outcomes.
Tan WS; Grajales V; Contieri R; Hensley P; Bree K; Msaouel P; Guo CC; Nogueras-Gonzalez GM; Navai N; Dinney CP; Kamat AM
Eur Urol Open Sci; 2023 Jul; 53():16-22. PubMed ID: 37441349
[TBL] [Abstract][Full Text] [Related]
12. Second transurethral resection and prognosis of high-grade non-muscle invasive bladder cancer in patients not receiving bacillus Calmette-Guérin.
Angulo JC; Palou J; García-Tello A; de Fata FR; Rodríguez O; Villavicencio H
Actas Urol Esp; 2014 Apr; 38(3):164-71. PubMed ID: 24613147
[TBL] [Abstract][Full Text] [Related]
13. Construction of predictive models for cancer-specific survival of patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: results from a multicenter retrospective study.
Nishiyama N; Kitamura H; Hotta H; Takahashi A; Yanase M; Itoh N; Tachiki H; Miyao N; Matsukawa M; Kunishima Y; Taguchi K; Masumori N
Jpn J Clin Oncol; 2014 Nov; 44(11):1101-8. PubMed ID: 25139163
[TBL] [Abstract][Full Text] [Related]
14. Long-term Recurrence and Progression Patterns in a Contemporary Series of Patients with Carcinoma In Situ of the Bladder With or Without Associated Ta/T1 Disease Treated with Bacillus Calmette-Guérin: Implications for Risk-adapted Follow-up.
Subiela JD; Rodríguez Faba Ó; Aumatell J; Gonzalez-Padilla DA; Rosales Bordes A; Huguet J; Krajewski W; Algaba F; López Curtis D; Brasero Burgos J; Sánchez González Á; Jiménez Cidre MÁ; Burgos Revilla FJ; Breda A; Palou J
Eur Urol Focus; 2023 Mar; 9(2):325-332. PubMed ID: 36163105
[TBL] [Abstract][Full Text] [Related]
15. The results of concurrent chemo-radiotherapy for recurrence after treatment with bacillus Calmette-Guérin for non-muscle-invasive bladder cancer: is immediate cystectomy always necessary?
Wo JY; Shipley WU; Dahl DM; Coen JJ; Heney NM; Kaufman DS; Zietman AL
BJU Int; 2009 Jul; 104(2):179-83. PubMed ID: 19154448
[TBL] [Abstract][Full Text] [Related]
16. The case for conservative management in the treatment of patients with non-muscle-invasive micropapillary bladder carcinoma without carcinoma in situ.
Gaya JM; Palou J; Algaba F; Arce J; Rodríguez-Faba O; Villavicencio H
Can J Urol; 2010 Oct; 17(5):5370-6. PubMed ID: 20974029
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors and risk groups in T1G3 non-muscle-invasive bladder cancer patients initially treated with Bacillus Calmette-Guérin: results of a retrospective multicenter study of 2451 patients.
Gontero P; Sylvester R; Pisano F; Joniau S; Vander Eeckt K; Serretta V; Larré S; Di Stasi S; Van Rhijn B; Witjes AJ; Grotenhuis AJ; Kiemeney LA; Colombo R; Briganti A; Babjuk M; Malmström PU; Oderda M; Irani J; Malats N; Baniel J; Mano R; Cai T; Cha EK; Ardelt P; Varkarakis J; Bartoletti R; Spahn M; Johansson R; Frea B; Soukup V; Xylinas E; Dalbagni G; Karnes RJ; Shariat SF; Palou J
Eur Urol; 2015 Jan; 67(1):74-82. PubMed ID: 25043942
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes of primary bladder carcinoma in situ in a contemporary series.
Chade DC; Shariat SF; Godoy G; Savage CJ; Cronin AM; Bochner BH; Donat SM; Herr HW; Dalbagni G
J Urol; 2010 Jul; 184(1):74-80. PubMed ID: 20546806
[TBL] [Abstract][Full Text] [Related]
19. Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor.
Huguet J; Crego M; Sabaté S; Salvador J; Palou J; Villavicencio H
Eur Urol; 2005 Jul; 48(1):53-9; discussion 59. PubMed ID: 15967252
[TBL] [Abstract][Full Text] [Related]
20. EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guérin.
Cambier S; Sylvester RJ; Collette L; Gontero P; Brausi MA; van Andel G; Kirkels WJ; Silva FC; Oosterlinck W; Prescott S; Kirkali Z; Powell PH; de Reijke TM; Turkeri L; Collette S; Oddens J
Eur Urol; 2016 Jan; 69(1):60-9. PubMed ID: 26210894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
